Kazuko Kojima

Title: Kazuko Kojima: Innovator in Medicinal Chemistry

Introduction

Kazuko Kojima is a notable inventor based in Iruma-gun, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on opioid antagonists.

Latest Patents

Kojima holds a patent for 4-(2-furoyl)aminopiperidines, which are intermediates in synthesizing the same. This patent describes novel 4-(2-furoyl)aminopiperidines represented by a specific general formula. The invention includes their synthetic intermediates, processes for their preparation, and medicinal uses. The derivatives possess opioid μ antagonistic activity and are useful for treating or preventing side effects caused by μ receptor agonists, such as constipation, nausea/emesis, and itch. They are also beneficial for conditions like idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome, and chronic pruritus.

Career Highlights

Throughout his career, Kojima has worked with prominent companies in the pharmaceutical industry, including Kyorin Pharmaceutical Co., Ltd. and Nisshin Pharma Inc. His work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Kojima has collaborated with notable colleagues, including Rie Shibayama and Kouichirou Hagihara. These collaborations have contributed to the success of his research and innovations in the field.

Conclusion

Kazuko Kojima's contributions to medicinal chemistry, particularly through his patent on 4-(2-furoyl)aminopiperidines, highlight his role as an innovator in the pharmaceutical industry. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.